Fundraising Fox

Cellular Longevity

San Francisco, US · Founded 2019 · Delaware corporation · 6 known investors

Biotech

Founders & leadership

Cellular Longevity was founded in 2019 by Celine-Lea Halioua-Haubold.

CH
Celine-Lea Halioua-HauboldFounder

Board

LD
Laura DemingBoard director
KZ
Kevin ZhangBoard director
LR
Linda RhodesBoard director
BS
Blake SchollBoard director

Investors · 6

Collaborative Fundreported · 2 sourcesNew York · $500K – $1M
First Round Capitalreported · 2 sourcesSan Francisco · $1M – $7M
Khosla Venturesreported · 2 sourcesMenlo Park · $5K – $50M
Lachy Groomreported

Also in the syndicate · 2

Box GroupThe Longevity Fund

Funding

SEC filings, press & company announcements

$137.3M disclosed across 6 of 7 rounds · 2020–2024

▶$22.2MraisedOct 2024 · 12 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Laura DemingDirector
  • Linda RhodesDirector
  • Celine-Lea Halioua-HauboldExecutive Officer, Director
  • Kevin ZhangDirector
  • Blake SchollDirector
Offering amount
$32.5M
Amount sold
$22.2M
First sale
Oct 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$76.3MraisedMar 2024 · 38 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Blake SchollDirector
  • Kevin ZhangDirector
  • Celine-Lea Halioua-HauboldExecutive Officer, Director
  • Laura DemingDirector
Offering amount
$76.3M
Amount sold
$76.3M
First sale
Mar 2024
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$27.7MraisedOct 2021 · 42 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Celine-Lea Halioua-HauboldExecutive Officer, Director
Offering amount
$28.8M
Amount sold
$27.7M
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$831.5KraisedJun 2021 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Celine-Lea Halioua-HauboldExecutive Officer, Director
Offering amount
$4M
Amount sold
$831.5K
First sale
Dec 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.4MraisedJun 2021 · 28 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Celine-Lea Halioua-HauboldExecutive Officer, Director
Offering amount
$5.4M
Amount sold
$5.4M
First sale
Sep 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.9MraisedJan 2020 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Celine-Lea Halioua-HauboldExecutive Officer, Director
Offering amount
$4.9M
Amount sold
$4.9M
First sale
Jan 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Lowenstein Represents Startup Loyal in $27 Million Series A Funding Round Promoting Longevity for Dogs | Lowenstein Sandler LLPlowenstein.com · Jun 2023

Frequently asked questions

Who founded Cellular Longevity?
Cellular Longevity was founded by Celine-Lea Halioua-Haubold in 2019.
Who are Cellular Longevity's investors?
Cellular Longevity's investors include Collaborative Fund, First Round Capital, Khosla Ventures, Lachy Groom.
How much funding has Cellular Longevity raised?
Cellular Longevity has disclosed $137.3M raised across 6 of its 7 known rounds.
Where is Cellular Longevity headquartered?
Cellular Longevity is headquartered in San Francisco, US.